Assessment of Parkinson disease: what do we need to show neuroprotection?
Ybot-Gorrin, Isabel
Assessment of Parkinson disease: what do we need to show neuroprotection? [electronic resource] - The neurologist Nov 2011 - S21-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
2331-2637
10.1097/NRL.0b013e31823966c6 doi
Activities of Daily Living
Clinical Trials as Topic
Disease Progression
Humans
Neuroimaging--methods
Neuroprotective Agents--therapeutic use
Neuropsychological Tests
Parkinson Disease--drug therapy
Assessment of Parkinson disease: what do we need to show neuroprotection? [electronic resource] - The neurologist Nov 2011 - S21-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
2331-2637
10.1097/NRL.0b013e31823966c6 doi
Activities of Daily Living
Clinical Trials as Topic
Disease Progression
Humans
Neuroimaging--methods
Neuroprotective Agents--therapeutic use
Neuropsychological Tests
Parkinson Disease--drug therapy